| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Proceeds from exercises of stock options | 2,100 | 392 |
| Issuance costs in relation to at-the-market equity offering | 0 | 0 |
| Net cash provided by financing activities | 16,773 | 14,807 |
| Net (decrease) increase in cash and cash equivalents | -22,824 | -11,689 |
| Cash and cash equivalents at beginning of period | 118,038 | - |
| Cash and cash equivalents at end of period | 95,214 | - |
PULSE BIOSCIENCES, INC. (PLSE)
PULSE BIOSCIENCES, INC. (PLSE)